Pet Asthma Treatment Market By Treatment Type (Medications, {Bronchodilators, Corticosteroids, Antihistamines, Leukotriene Modifiers, Antibiotics}, Inhalation Therapy, Immunotherapy, Alternative Therapies), By Diagnosis Method (Physical Examination, X-rays, Bronchoscopy, Blood Tests, Allergy Testing), By Animal Type (Dogs, Cats, Others), By Mode of Administration (Inhalation, Oral, Injectable), By Distribution Channel (Online Pharmacies, Retail Pet Pharmacies, Pet Specialty Stores), By End User (Veterinary Hospitals, Homecare Settings, Veterinary Research Institutes), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles and Market Forecast, 2025 – 2035

---

Industry Outlook

The Pet Asthma Treatment Market accounted for USD 405.39 Million in 2024 and USD 431.46 Million in 2025 and is expected to reach USD 804.60 Million by 2035, growing at a CAGR of around 6.43% between 2025 and 2035. Treatment for pet asthma means managing and reducing the symptoms of asthma in cats and dogs. Doctors prescribe bronchodilators and corticosteroids to regulate breathing and ease swelling, plus inhaled therapy for ease of delivering medication to the lungs. Since pet owners are becoming more aware of pet respiratory problems and want expert help, the pet asthma treatment market is on the rise. Due to better ways to diagnose, increased pet ownership, and a trend toward treating pets like people, there is an increasing demand for good asthma treatments. The use of new treatments and better veterinary options is helping the market to develop.

Industry Experts Opinion

“Environmental modifications remain the most important strategy to decrease clinical signs in horses with severe equine asthma, while medical treatment relies on the use of anti-inflammatories and bronchodilators.”

• Dr. Bettina Dunkel – Professor in Equine Medicine, Royal Veterinary College

Report Scope:

Market Dynamics

Pet ownership is increasing, and more people treat pets like family, leading to a higher demand for asthma treatments.

Higher numbers of pets in urban and wealthy areas are boosting the need for pet asthma treatment, driving up the market’s growth. As pet ownership rises, especially with animals that can cause asthma, there is a demand for new healthcare products for asthma sufferers. Pets are considered part of the family, so their health is handled just as seriously as human health. Because owners have a different mindset, their pets now see veterinarians regularly, illnesses are recognized earlier, and unique treatments are used. Owners are happy to spend their money on medicines, inhalers, and good plans for looking after their pets in the long run. As pet owners become more informed about asthma in animals, nurses try to prevent problems and act quickly, which leads to a constant demand for good treatment.

The bond between people and their pets is having an impact on the way pet products are bought and sold. Rather than just treating the symptoms, pet parents now look for new treatments such as bronchodilators, corticosteroids, and inhalation therapy to manage their pets’ asthma. There is also strong support for market expansion because more e-commerce and veterinary clinics are now offering these products and services. As the financial situation in developing nations gets better and Western ideas become more popular, many pets now benefit from newer and more valuable medical treatments. Pet humanization is causing the veterinary sector to grow, which is encouraging firms to innovate asthma treatments for animals. With pets now being seen as friends who need proper medical care, the worldwide demand for asthma treatments has improved, and the pet asthma treatment market is expanding.

Pollution and allergens in cities are causing more breathing problems in pets.

Pollution and different types of airborne allergens in towns and cities are leading to more cases of respiratory problems in cats and dogs. Because cities are growing and there is more industry, domestic pets are commonly inhaling exhaust, smoke, dust, and different chemicals. When exposed to these airborne irritants, people with asthma can start to wheeze, cough, and have trouble breathing. Because cities are often full of pollution and allergens like mould, pollen, and pets, especially inside, it makes it much harder for people with respiratory issues. Because of this, pet owners are turning to veterinarians in larger numbers for help with asthma, increasing the need for treatments for animals with asthma.

Because pets are very aware of any health changes in the environment, their owners in cities should visit a vet immediately if their pet starts having respiratory symptoms. Since city living means pets spend more time indoors, owners now rely on veterinary care for things like diagnosing asthma and giving pets bronchodilators and corticosteroid drugs. More and more owners are realizing that keeping the home clean and safe for pets is important. More pets are suffering from breathing disorders, and both pharmaceutical firms and veterinary clinics are designing new treatments and supporting early detection. As a result, the market for pet asthma treatments is increasing steadily due to the frequent environmental difficulties in most urban areas. More treatments are needed, and researchers are introducing better gadgets and medications that make breathing easier for pets living in polluted spaces.

Pet asthma treatments are expensive, making it hard for some owners to afford them.

Expensive treatments for pet asthma are an important barrier to the development of this market. For most pet owners, bronchodilators and corticosteroids, and procedures like X-rays or bronchoscopy are too costly. Maintaining and refilling inhalation devices and special treatments regularly increases costs. For many pet owners, the regular expenses for their pet’s care can be very challenging, mainly in low and middle-income areas. This is why some pets do not get the treatment they need, making their condition worse over the months. In many nations, the inability to get insurance for pets means people cannot receive good asthma care for their pets. Because of this financial gap, not everyone can use the treatment, reducing the market’s overall reach.

Along with costs for medication, the frequent need for appointments and changes to treatment at the vet add to the cost for pet owners. The use of specialized treatments such as immunotherapy and inhalation therapy leads to increased costs because they usually require professional help and special devices. Many families think that the expense isn’t worthwhile, mainly when symptoms of asthma are moderate or occur less frequently. For this reason, some result in treatment gaps or rely on cheaper but less useful cures.

Further, not having enough affordable generic asthma drugs reduces what people with limited budgets can choose from. Limited resources often stop people from getting early care and slow the use of newer treatment options. As a result, people with pets affected by asthma do want treatment, but affordability issues keep the market from growing to its maximum in budget-conscious regions. Using subsidies, promoting generic drugs, and providing insurance could both ease pet asthma treatment costs and open new opportunities for growth in the industry.

New technology, like pet health monitors and online vet care can help catch asthma early.

The arrival of pet health monitors and ways to see a vet remotely is giving rise to meaningful opportunities for the market of pet asthma treatments. Due to wearable pet health devices, owners and veterinarians can catch signs that a pet is having trouble breathing through changes in their breathing, activity or sleep. Because of these devices, authorities can get alerts and deal with a situation before it gets worse. The sooner a disease is diagnosed, the more successful treatment will be, and the less costly long-term treatment will be. When pets live in urban places with many environmental allergens, these technologies help keep them healthy and happy.

The connection between smart devices and pet mobile apps makes it simpler for pet owners to oversee their animals and give vets updates over long distances. With digital tools, more people learn about early treatment and begin to trust it. Due to tele-veterinary options, people can now get advice without travelling to the veterinarian’s office. This works well for people with mild asthma since both monitoring and prescription adjustments are handled remotely. They also help places where there are no local veterinary centres. With newer technologies in pet health care, using the internet for regular visits and detecting early signs is likely to become more common. Because these technologies are easy to use and budget-friendly, pet owners are encouraged to treat their pets early. There are already discussions between pharmaceutical firms and tech startups about blending the use of monitoring devices with medicine for people with chronic asthma.

All of this innovation has created a new opportunity in veterinary medicine, letting us manage asthma with personalized and preventive medicine. Since many pet owners are choosing these smart systems, the market for pet asthma treatments may see growth, allowing businesses to introduce improved ways and tools for pet care.

Products that prevent asthma, like air purifiers for homes with pets, are becoming popular.

Promising prospects for pet asthma treatment come from inventing new products such as air purifiers for pets. With knowledge of what can cause asthma attacks, many regular pet owners are choosing to buy devices that lower dust, pollen, pet dander and other allergens in their homes. Hen having an air purifier in the home helps reduce the risk and number of asthma attacks in pets that are sensitive. Because of this strategy, people being treated for their pets’ asthma are looking at all types of treatments to help their pets. More pet owners are humanizing their animals, spending money on things that keep their pets happy and healthy.

The increasing use of such preventive items is encouraging new ideas and widening the options for caring for pet asthma. Modern air purifiers are often sold as being good for pet owners because they have strong filtration and are known to benefit lung health. This advancement helps pets with asthma and also protects animals that are more likely to develop breathing troubles.

More retailers and veterinary clinics are offering these products as ways to help reduce symptoms of asthma. Because awareness about preventing pet health issues is rising, manufacturers are now able to introduce new items for pet owners, including portable air purifiers and smart sensors for monitoring air pollution. This trend is expected to benefit the pet asthma treatment market by offering more ways to make money and ensuring care starts early which helps pets live better and saves owners money over time.

Segment Analysis

Based on Treatment Type, the Pet Asthma Treatment Market is segmented into Medications (Bronchodilators, Corticosteroids, Antihistamines, Leukotriene Modifiers, Antibiotics), Inhalation Therapy, Immunotherapy, and Alternative Therapies. The use of bronchodilators and corticosteroids for managing pet asthma is the main reason why Medications are the largest part of the industry. Veterinarians and pet owners like these drugs because they provide immediate support and are the first choice for treatment. Even though Inhalation Therapy is growing popular because it helps medicine reach the lungs, it is not as common as pills or liquids.

Based on Diagnosis Method, the Pet Asthma Treatment Market is segmented into Physical Examination, X-rays, Bronchoscopy, Blood Tests, and Allergy Testing. Physical Examination is the biggest sector in the market since it is the easiest and most typical way to diagnose in veterinary settings. Checking this is often the first thing done to see if a pet has respiratory distress and is usually only the start of further checks. Doctors also rely on X-rays and allergy tests to help them figure out what causes asthma. Technologies such as Bronchoscopy and Blood Tests are effective but are usually not used very often because they are more costly and need people with special knowledge.

Regional Analysis

The North American Pet Asthma Treatment Market is witnessing strong growth, driven by increased pet ownership, greater awareness of pet health, and the availability of advanced veterinary care. In this area, more pet guardians are bringing their animals to the vet for respiratory health problems, causing more requests for asthma treatment. Since there are known veterinary organizations making these drugs and they are easily accessible, the market for these products can only grow. Many parents are starting to use inhalers which provide more targeted relief with a smaller risk of side effects. Visiting a vet or taking part in a wellness program is key to getting pets checked and helping detect asthma early. This growing trend is further supported by insurance coverage for chronic pet conditions, making long-term asthma treatment more affordable and encouraging consistent veterinary visits.

The Asia Pacific Pet Asthma Treatment Market is growing steadily due to rising urbanization, increasing pet adoption, and gradual improvements in veterinary infrastructure. Because pet humanization is growing in China, Japan and India, owners there pay more attention to how healthy their pets are, especially when it comes to respiratory diseases. Although pet asthma is not well known in some places, more campaigns and improved access to vets are helping fill in the knowledge gap. In addition, patients now have additional choices in treatment because generic medicines and alternative therapies are more available in areas where healthcare is costly. A concern for animal welfare means the region has good opportunities for progress in treating pet asthma.

Competitive Landscape

Established pharmaceutical organizations and unique animal health companies form the competitive makeup of the Pet Asthma Treatment Market. Zoetis, Boehringer Ingelheim, Elanco and Merck & Co. lead the industry with their strong research and new products for pets with asthma and other respiratory conditions. They strive to increase their offerings by purchasing other companies, forming partnerships and investing often in state-of-the-art treatment solutions.

Provetica LLC and Vetoquinol are among emerging firms that are progressing by bringing out focused treatments and gaining more recognition in this field. Market competition also grows because of companies like Virbac and Neogen Corporation which support a broad selection of treatments. The Pet Asthma Treatment Market is very competitive because of ongoing inventions, cooperative efforts and joint efforts aimed at treating pet asthma.

Pet Asthma Treatment Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Recent Developments:

• In September 2024, Boehringer Ingelheim acquired Saiba Animal Health, adding an innovative technology platform to its pet therapeutics R&D portfolio.

Report Coverage:

By Treatment Type

• Medications
  • Bronchodilators
  • Corticosteroids
  • Antihistamines
  • Leukotriene Modifiers
  • Antibiotics
• Inhalation Therapy
• Immunotherapy
• Alternative Therapies

By Diagnosis Method

• Physical Examination
• X-rays
• Bronchoscopy
• Blood Tests
• Allergy Testing

By Animal Type

• Dogs
• Cats
• Others

By Mode of Administration

• Inhalation
• Oral
• Injectable

By Distribution Channel

• Online Pharmacies
• Retail Pet Pharmacies
• Pet Specialty Stores

By End User

• Veterinary Hospitals
• Homecare Settings
• Veterinary Research Institutes

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Zoetis Inc.
• Boehringer Ingelheim Animal Health
• Elanco Animal Health Incorporated
• Merck Animal Health
• Vetoquinol S.A.
• Dechra Pharmaceuticals PLC
• Virbac
• Norbrook Laboratories Ltd.
• Ceva Santé Animale
• Kindred Biosciences Inc.
• Bimeda Animal Health
• Orion Corporation
• VetInnovations Inc.
• PetIQ, Inc.
• AVMA

Frequently Asked Questions (FAQs)